about
Treatment of anaerobic infectionCould chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.Ethical issues relating to the use of antimicrobial therapy in older adults.Selecting anti-microbial treatment of aerobic vaginitis.Use of anti-infective agents during lactation: Part 2--Aminoglycosides, macrolides, quinolones, sulfonamides, trimethoprim, tetracyclines, chloramphenicol, clindamycin, and metronidazole.Clindamycin Resistance among Staphylococcus Aureus Isolated at Mbarara Regional Referral Hospital, in South Western UgandaTopical antibiotics for preventing surgical site infection in wounds healing by primary intention.Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug.The prevalence of inducible clindamycin resistance among staphylococci in a tertiary care hospital - a study from the garhwal hills of uttarakhand, IndiaA new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.Metronidazole single versus multiple daily dosing in serious intraabdominal/pelvic and diabetic foot infections.Medication-related complications in the trauma patient.Antimicrobial resistance in Bacteroides spp.: occurrence and dissemination.Antimicrobial treatment of anaerobic infections.Addressing Antiretroviral Therapy-Associated Drug-Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low-Income and Resource-Limited Settings.Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci.Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway.Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin.An improved electrochemical aptasensor for chloramphenicol detection based on aptamer incorporated gelatinePhenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLSB) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran.The prevalence of inducible and constitutive clindamycin resistance among the nasal isolates of staphylococci.Chemiluminescent aptasensor for chloramphenicol based on N-(4-aminobutyl)-N-ethylisoluminol-functionalized flower-like gold nanostructures and magnetic nanoparticles.Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus.
P2860
Q28258687-2924A8A4-7E33-4085-AEC5-8077582AC7D6Q30726683-FBE7DB90-197D-47DA-AC0B-06BA2EAC458AQ34398557-2CE1F137-44EA-49F2-8FEC-1AB239811207Q34472797-4D6C480F-31C6-4D1F-9F7F-A4259E9E00E6Q34533754-59178C30-25A5-4BB1-9DA5-DDF48D2158DBQ35671413-4EAF33E3-CDCE-4698-9CBA-7FBE72C98138Q36184028-50755F52-21BC-4514-8C7D-CCA53FEB220DQ36452385-AC4C0770-D5A1-4730-B39D-02826C1A9F9AQ36622487-C9D98019-AFA6-4EA4-9151-10A2A4DD09DBQ36792749-62AA7FCD-CC23-423D-A103-8BC0ACEECF77Q36940327-A19A6BED-818D-4898-9119-194BBE174AB0Q37121344-9F472718-91EB-4514-A7CD-8F6BA7EA6865Q37470575-E34AED7A-CC75-4044-AD85-BC485D368B36Q37867124-A1772668-4075-4E08-91D5-5039CBCB2C11Q40051462-AB9E32CB-3BB9-4D12-A66E-94F671F61B66Q40133451-7D0D00A6-5D6A-4575-B0D8-2B1CBC9C42D2Q40420110-41E755A0-727C-4527-8BB3-62F9A4671748Q40535533-3011C719-4504-4BA8-BA4D-F454A18973AAQ40647544-2E217B3B-4407-40D4-83F4-EE24E1B41FF0Q42415273-809CCD7D-7419-4AF1-AEF6-20709F49D0D3Q42968827-F07A1D98-650B-4121-8958-371DDD2AB422Q53370470-857F7845-E6EB-4332-BA61-7DE0F2710398Q54393814-2F54CB65-5724-4009-939D-96C443724023
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clindamycin, metronidazole, and chloramphenicol.
@ast
Clindamycin, metronidazole, and chloramphenicol.
@en
type
label
Clindamycin, metronidazole, and chloramphenicol.
@ast
Clindamycin, metronidazole, and chloramphenicol.
@en
prefLabel
Clindamycin, metronidazole, and chloramphenicol.
@ast
Clindamycin, metronidazole, and chloramphenicol.
@en
P356
P1476
Clindamycin, metronidazole, and chloramphenicol.
@en
P2093
M J Kasten
P304
P356
10.4065/74.8.825
P407
P577
1999-08-01T00:00:00Z